Health outcomes in decompensated congestive heart failure: A comparison of tertiary hospitals in Brazil and United States

International Journal of Cardiology

Volumn 102, Issue 1, 2005, Pages 71-77

  Rohde, Luis E ^a   Clausell, Nadine ^a   Ribeiro, Jorge Pinto ^a   Goldraich, Lívia ^a   Netto, Rafael ^a   Dec, G William ^b   DiSalvo, Thomas G ^b   Polanczyk, Carísi A ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Congestive heart failure; International; Outcomes and treatment

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; METOPROLOL; NITRATE; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; BRAZIL; CLINICAL PRACTICE; CLINICAL TRIAL; COHORT ANALYSIS; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CULTURAL ANTHROPOLOGY; EVIDENCE BASED MEDICINE; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEALTH ECONOMICS; HEART ARRHYTHMIA; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; HYPERTENSION; INTERVIEW; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MORTALITY; MULTIVARIATE ANALYSIS; OBSERVATION; PREVALENCE; PRIORITY JOURNAL; RHEUMATIC HEART DISEASE; SCORING SYSTEM; STROKE; TEACHING HOSPITAL; TELEPHONE; TREATMENT OUTCOME; UNITED STATES; VALVULAR HEART DISEASE;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BRAZIL; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HOSPITAL MORTALITY; HOSPITALS, TEACHING; HUMANS; INPATIENTS; LENGTH OF STAY; MALE; MYOCARDIAL ISCHEMIA; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT DISCHARGE; PATIENT READMISSION; PRESCRIPTIONS, DRUG; PREVALENCE; PROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; UNITED STATES;

EID: 18844420369     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2004.04.006     Document Type: Article

References (29)

1. American Heart Association, 2004. Heart Disease and Stroke Statistical update. Available at: http://www.americanheart.org/statistics Accessed on February 2nd, 2004.
2. D. Levy, S. Kenchaiah, and M.G. Larson Long-term trends in the incidence of and survival with heart failure N. Engl. J. Med. 347 2002 1397 1402
3. G.F. Mendez, and M.R. Cowie The epidemiological features of heart failure in developing countries: a review of the literature Int. J. Cardiol. 80 2001 213 219
4. DATA-SUS. Available at: http://www.tabnet.datasus.gov.br. Accessed on March 21, 2002.
5. S. Singh, R. Fletcher, S. Fisher, and B. Singh Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia: survival trial of amiodarone in patients with congestive heart failure N. Engl. J. Med. 333 1995 77 82
6. H.C. Doval, D.L. Nul, and H.O. Grancelli Randomized trial of low-dose amiodarone in severe congestive heart failure Lancet 344 1994 493 498
7. D.J. van Veldhuisen, A. Charlesworth, H.J. Crijns, K.L. Lie, and J.R. Hampton Differences in drug treatment of chronic heart failure between European countries Eur. Heart J. 20 1999 666 672
8. B.M. Massie, J.G. Cleland, and P.W. Armstrong Regional differences in the characteristics and treatment of patients participating in an international heart failure trial. The Assessment of Treatment with Lisinopril and Survival (ATLAS) Trial Investigators J. Card. Fail. 4 1998 3 8
9. J.G.F. Cleland, K. Swedberg, and F. Follath The EuroHeart Failure survey programme-a survey on the quality of care among patients with heart failure: Part 1. Patient characteristics and diagnosis Eur. Heart J. 24 2003 442 463
10. M. Komajda, F. Follath, and K. Swedberg The EuroHeart Failure survey programme-a survey on the quality of care among patients with heart failure: Part 2. Treatment Eur. Heart J. 24 2003 464 474
11. K.J. Carlson, D.C. Lee, A.H. Garoll, M. Leahy, and R.A. Johnson An analysis of physicians' reasons for prescribing long-term digitalis therapy in outpatients J. Chronic. Dis. 38 1985 733 739
12. E. Braunwald The history E. Braunwald P. Zipes P. Libby Heart disease. A textbook of cardiovascular medicine 6th ed. 2001 Saunders Philadelphia 27 44
13. M. Charlson, T.P. Szatrowski, J. Peterson, and J. Gold Validation of a combined comorbidity index J. Clin. Epidemiol. 47 1994 1245
14. Euroaspire I and II Groups Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries Lancet 357 2001 995 1001
15. K. Eagle for the GRACE Investigators Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings form the Global Registry of Acute Coronary Events Lancet 359 2002 373 377
16. K. Matsui, C.A. Polanczyk, and J.M. Gaspoz Management of patients with acute myocardial infarction at five academic medical centers: clinical characteristics, resource utilization, and outcome J. Investig. Med. 47 1999 134 140
17. Hunt SA, Baker DW, Chin MH, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2001. Available at: http://www.acc.org/clinical/guidelines/failure/ hf_index.htlm. Accessed on January 2004.
18. II Diretrizes da Sociedade Brasileira de Cardiologia para Diagnóstico e Tratamento da Insuficiência Cardíaca Arq. Bras. Cardiol. 72 Suppl. I 1999 1 30
19. W.J. Remme, and K. Swedber Task force for the diagnosis and treatment of chronic heart failure, European Society of Cardiology Eur. Heart J. 22 2001 1527 1560
20. J.G.F. Cleland, A. Cohen-Solal, J. Cosin Aguilar the Study Group on Diagnosis of the Working Group on Heart Failure of The European Society of Cardiology Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey Lancet 360 2002 1631 1639
21. M. Packer, A.J.S. Coats, and M.B. Fowler Effect of carvedilol on survival in severe chronic heart failure N. Engl. J. Med. 344 2001 1651 1658
22. S. Stewart, L. Blue, S Capewell, J.D. Horowitz, and J.J. McMurray Poles apart, but are they the same? A comparative study of Australia and Scottish patients with chronic heart failure Eur. J. Heart Fail. 3 2001 249 255
23. W. D'Hoore, C. Sicotte, and C. Tilquin Risk adjustment in outcome assessment: the Charlson comorbidity index Methods Inf. Med. 32 1993 382
24. W. D'Hoore, A. Bouckaert, and C. Tilquin Risk adjustment in outcome assessment: the Charlson comorbidity index with administrative data bases J. Clin. Epidemiol. 49 1996 1429
25. C.A. Polanczyk, L.E. Rohde, E.A. Philbin, and T. Di Salvo A new casemix adjustment index for hospital mortality among patients with congestive heart failure Med. Care 36 1998 1489 1499
26. W.A. Ghali, R.E. Hall, A.K. Rosen, A.S. Ash, and M.A. Moskovitz Searching for an improved clinical comorbidity index for use with ICD-9-CM administrative data J. Clin. Epidemiol. 46 1996 273
27. The CIBIS-II Investigators The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial Lancet 353 1999 9 13
28. The MERIT-HF Investigators Effect of metropolol CR/XL in chronic heart failure: metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF) Lancet 33 1999 2001 2007
29. B. Pitt, F. Zannad, and W.J. Remme The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators N. Engl. J. Med. 341 1999 709 717